UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN C000000157
Receipt No. R000000227
Scientific Title Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study)
Date of disclosure of the study information 2005/09/12
Last modified on 2011/09/09 10:02:37

No. Disposal Last modified on Item of update
1 Insert 2005/09/11 08:21:39
2 Update 2005/11/11 00:41:09 Organization
Organization
Division name
Division name
3 Update 2005/11/11 00:42:19 Public title
Public title
Acronym
Acronym
4 Update 2005/11/11 00:46:35 Name of person sending information
Name of person sending information
Institute
5 Update 2006/03/24 18:24:48 Recruitment status
6 Update 2006/09/21 06:39:29 Homepage URL
7 Update 2007/09/11 09:16:19 Publication of results
8 Update 2009/03/25 07:10:55 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2010/03/11 09:10:24 Acronym
Acronym
10 Update 2010/03/11 09:11:37 Recruitment status
11 Update 2011/03/08 14:25:41 Publication of results
12 Update 2011/03/08 14:29:04 Other related information
Other related information
13 Update 2011/09/09 10:02:37 Post marketing survey by drug manufacture etc., specified by Japanese law.


Contact us.